TokenPost·
Spruce Biosciences Posts $24 Million Q3 Loss, $8.51 Per Share
Cash and cash equivalents rose to $87.7 million on Sept. 30, 2026, from $48.9 million at the end of 2025.
More news
- TokenPostStrive's Bitcoin Holdings Rise to 43,153 BTC in Nov. 9 Tally
- TokenPostBlackRock's Bitcoin ETF Posts Seventh Straight Outflow of $213 Million
- TokenPostAbundia Revenue Rises 51% as Loss Narrows Amid Going-Concern Doubt
- CryptoPotatoPi Network’s PI Rockets 8% From ATL as Bitcoin Struggles to Hold $74K: Market Watch
- UnchainedCoinbase, Kalshi and Jump Trading Urge Judge to Keep Single-Stock Perps Trading
- TokenPostQatari Official Disputes U.S.-Iran Plan Details as Talks Continue